Cerebellar volume as an outcome measure in therapeutic trials of primary progressive multiple sclerosis

被引：0
|
作者：
Inglese, M. [1 ]
Petracca, M. [1 ]
Saiote, C. [1 ]
Ruggieri, S. [1 ]
Fabian, M. [1 ]
Howard, J. [2 ]
Riley, C. [3 ]
Krieger, S. [1 ]
Miller, A. [1 ]
Lublin, F. [1 ]
Sormani, M. P. [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] NYU, Langone Med Ctr, New York, NY USA
[3] Columbia Univ, Med Ctr, New York, NY USA
[4] Univ Genoa, Genoa, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P466
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [1] Cerebellar volume as imaging outcome in progressive multiple sclerosis
    Inglese, Matilde
    Petracca, Maria
    Mormina, Enricomaria
    Achiron, Anat
    Straus-Farber, Rebecca
    Miron, Shmuel
    Fabian, Michelle
    Krieger, Stephen
    Miller, Aaron
    Lublin, Fred
    Sormani, Maria Pia
    PLOS ONE, 2017, 12 (04):
  • [2] Spinal cord atrophy as a primary outcome measure in primary progressive multiple sclerosis neuroprotective trials
    Cawley, N.
    Abdel-Aziz, K.
    Schneider, T.
    Altmann, D.
    Wheeler-Kingshott, C. A. M.
    Miller, D. H.
    Thompson, A. J.
    Ciccarelli, O.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 189 - 190
  • [3] Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis
    Cawley, Niamh
    Tur, Carmen
    Prados, Ferran
    Plantone, Domenico
    Kearney, Hugh
    Abdel-Aziz, Khaled
    Ourselin, Sebastian
    Wheeler-Kingshott, Claudia A. M. Gandini
    Miller, David H.
    Thompson, Alan J.
    Ciccarelli, Olga
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (07) : 932 - 941
  • [4] Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis
    Leary, SM
    Stevenson, VL
    Miller, DH
    Thompson, AJ
    JOURNAL OF NEUROLOGY, 1999, 246 (07) : 562 - 568
  • [5] Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis
    Siobhan M. Leary
    Valerie L. Stevenson
    David H. Miller
    A. J. Thompson
    Journal of Neurology, 1999, 246 : 562 - 568
  • [6] Imaging outcome measures for progressive multiple sclerosis trials
    Moccia, Marcello
    de Stefano, Nicola
    Barkhof, Frederik
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (12) : 1614 - 1626
  • [7] Clinical trials in multiple sclerosis - The importance of the outcome measure
    Zajicek, J
    Thompson, A
    Hobart, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08): : 1215 - 1215
  • [8] Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis (vol 23, pg 1, 2017)
    Cawley, N.
    Tur, C.
    Prados, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP30 - NP30
  • [9] Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis
    Koch, Marcus W.
    Mostert, Jop
    Repovic, Pavle
    Bowen, James D.
    Uitdehaag, Bernard
    Cutter, Gary
    NEUROLOGY, 2021, 96 (01) : E111 - E120
  • [10] The Use of MR Imaging as an Outcome Measure in Multiple Sclerosis Clinical Trials
    Bermel, Robert A.
    Fisher, Elizabeth
    Cohen, Jeffrey A.
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (04) : 687 - 701
12345